Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	Daily Top 10 COVID-19 papers DEU | ENG | ESP | FRA | ITA | POR | TUR | VNM

Ischemic Heart Disease

Free Subscription Articles published in Catheter Cardiovasc Interv Retrieve available abstracts of 256 articles: HTML format

Single Articles

May 2020
1. HARARI R, Bangalore S, Chang E, Shah B, et al
   COVID-19 complicated by acute myocardial infarction with extensive thrombus burden and cardiogenic shock.
   Catheter Cardiovasc Interv. 2020 May 19. doi: 10.1002/ccd.28992.
   PubMed     Abstract available
   
   
   
2. TAM CF, Cheung KS, Lam S, Wong A, et al
   Impact of coronavirus disease 2019 (COVID-19) outbreak on outcome of myocardial infarction in Hong Kong, China.
   Catheter Cardiovasc Interv. 2020 May 5. doi: 10.1002/ccd.28943.
   PubMed     Abstract available
   
   
   April 2020
3. PAHUJA M, Chehab O, Ranka S, Mishra T, et al
   Incidence and clinical outcomes of stroke in ST-elevation myocardial infarction and cardiogenic shock.
   Catheter Cardiovasc Interv. 2020 Apr 30. doi: 10.1002/ccd.28919.
   PubMed     Abstract available
   
   
   
4. LACOUR T, Semaan C, Genet T, Ivanes F, et al
   Insights for increased risk of failed fibrinolytic therapy and stent thrombosis associated with COVID-19 in ST-segment elevation myocardial infarction patients.
   Catheter Cardiovasc Interv. 2020 Apr 30. doi: 10.1002/ccd.28948.
   PubMed     Abstract available
   
   
   
5. XIAO Z, Xu C, Wang D, Zeng H, et al
   The experience of treating patients with acute myocardial infarction under the COVID-19 epidemic.
   Catheter Cardiovasc Interv. 2020 Apr 29. doi: 10.1002/ccd.28951.
   PubMed     Abstract available
   
   
   
6. SADEGHIPOUR P, Talasaz AH, Eslami V, Gerayeli B, et al
   Management of ST-segment-elevation myocardial infarction during the coronavirus disease 2019 (COVID-19) outbreak: Iranian"247" National Committee's position paper on primary percutaneous coronary intervention.
   Catheter Cardiovasc Interv. 2020 Apr 22. doi: 10.1002/ccd.28889.
   PubMed     Abstract available
   
   
   
7. MAHMUD E, Dauerman HL, Welt FG, Messenger JC, et al
   Management of Acute Myocardial Infarction During the COVID-19 Pandemic.
   Catheter Cardiovasc Interv. 2020 Apr 20. doi: 10.1002/ccd.28946.
   PubMed     Abstract available
   
   
   
8. GARCIA S, Schmidt CW, Garberich R, Henry TD, et al
   Temporal changes in patient characteristics and outcomes in ST-segment elevation myocardial infarction 2003-2018.
   Catheter Cardiovasc Interv. 2020 Apr 15. doi: 10.1002/ccd.28901.
   PubMed     Abstract available
   
   
   
9. BELARDI J, Lamelas P
   Bioabsorbable-polymer drug-eluting stents in acute myocardial infarction: Insights from the ULLISE registry.
   Catheter Cardiovasc Interv. 2020;95:E144-E145.
   PubMed     Abstract available
   
   
   March 2020
10. KHAN MS, Khan AR, Khan AI, Seo M, et al
    Comparison of revascularization strategies in patients with acute coronary syndrome and multivessel coronary disease: A systematic review and network meta-analysis.
    Catheter Cardiovasc Interv. 2020 Mar 28. doi: 10.1002/ccd.28855.
    PubMed     Abstract available
    
    
    
11. GRINES CL, Marshall JJ
    Invasive imaging of myocardial infarction patients: Is less or more better?
    Catheter Cardiovasc Interv. 2020;95:704-705.
    PubMed     Abstract available
    
    
    February 2020
12. HUDED CP, Kapadia SR, Ballout JA, Krishnaswamy A, et al
    Association of adoption of transradial access for percutaneous coronary intervention in ST elevation myocardial infarction with door-to-balloon time.
    Catheter Cardiovasc Interv. 2020 Feb 27. doi: 10.1002/ccd.28785.
    PubMed     Abstract available
    
    
    
13. NOAMAN S, O'Brien J, Andrianopoulos N, Brennan AL, et al
    Clinical outcomes following ST-elevation myocardial infarction secondary to stent thrombosis treated by percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2020 Feb 22. doi: 10.1002/ccd.28802.
    PubMed     Abstract available
    
    
    
14. YILDIZ M, Henry TD
    Preprocedure Thrombolysis In Myocardial Infarction (TIMI) flow grade: Has its time come and gone?
    Catheter Cardiovasc Interv. 2020;95:501-502.
    PubMed    
    
    
    
15. VEROUHIS D, Sorensson P, Gourine A, Henareh L, et al
    Long-term effect of remote ischemic conditioning on infarct size and clinical outcomes in patients with anterior ST-elevation myocardial infarction.
    Catheter Cardiovasc Interv. 2020 Feb 7. doi: 10.1002/ccd.28760.
    PubMed     Abstract available
    
    
    January 2020
16. MAHMUD E
    The COMPLETE and ISCHEMIA trials: Two contemporary studies showing percutaneous coronary intervention reduces the risk of myocardial infarction.
    Catheter Cardiovasc Interv. 2020 Jan 29. doi: 10.1002/ccd.28723.
    PubMed    
    
    
    
17. YOU J, Li H, Guo W, Li J, et al
    Platelet function testing guided antiplatelet therapy reduces cardiovascular events in Chinese patients with ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention: The PATROL study.
    Catheter Cardiovasc Interv. 2020 Jan 20. doi: 10.1002/ccd.28712.
    PubMed     Abstract available
    
    
    
18. TYLER JM, Henry TD
    Intraaortic balloon pump in myocardial infarction: Always, Never, or for the Right Patient?
    Catheter Cardiovasc Interv. 2020 Jan 20. doi: 10.1002/ccd.28683.
    PubMed     Abstract available
    
    
    
19. XU MX, Ruddy TD, Schoenhagen P, Bartel T, et al
    The CatLet score and outcome prediction in acute myocardial infarction for patients undergoing primary percutaneous intervention: A proof-of-concept study.
    Catheter Cardiovasc Interv. 2020 Jan 14. doi: 10.1002/ccd.28724.
    PubMed     Abstract available
    
    
    
20. SHAO C, Wang J, Li P, Yang J, et al
    Evaluation of a risk index for predicting short-term and long-term outcomes in patients with ST-elevation myocardial infarction.
    Catheter Cardiovasc Interv. 2020 Jan 10. doi: 10.1002/ccd.28706.
    PubMed     Abstract available
    
    
    
21. SHENG X, Qiao Z, Ge H, Sun J, et al
    Novel application of quantitative flow ratio for predicting microvascular dysfunction after ST-segment-elevation myocardial infarction.
    Catheter Cardiovasc Interv. 2020 Jan 8. doi: 10.1002/ccd.28718.
    PubMed     Abstract available
    
    
    December 2019
22. GARCIA-GARCIA HM, Adamo M, Soud M, Yacob O, et al
    Assessment of residual thrombus burden in patients with ST-segment elevation myocardial infarction undergoing bivalirudin versus unfractionated heparin infusion: The MATRIX (minimizing adverse hemorrhagic events by transradial access site and angioX)
    Catheter Cardiovasc Interv. 2019 Dec 28. doi: 10.1002/ccd.28661.
    PubMed     Abstract available
    
    
    
23. KHEIFETS M, Vaknin-Assa H, Greenberg G, Assali A, et al
    Outcomes of primary percutaneous cardiac intervention for ST elevation myocardial infarction with a saphenous vein graft culprit.
    Catheter Cardiovasc Interv. 2019 Dec 23. doi: 10.1002/ccd.28662.
    PubMed     Abstract available
    
    
    
24. VAUTRIN E, Jean ABP, Fourny M, Marliere S, et al
    Sex differences in coronary artery lesions and in-hospital outcomes for patients with ST-segment elevation myocardial infarction under the age of 45.
    Catheter Cardiovasc Interv. 2019 Dec 5. doi: 10.1002/ccd.28627.
    PubMed     Abstract available
    
    
    
25. CHANDIRAMANI R, Mehran R
    Examining the role of diabetes mellitus in ST-elevation myocardial infarction.
    Catheter Cardiovasc Interv. 2019;94:926-927.
    PubMed    
    
    
    November 2019
26. DHARMA S, Sari NY, Santoso A, Sukmawan R, et al
    Association of plasma pentraxin 3 concentration with angiographic and clinical outcomes in patients with acute ST-segment elevation myocardial infarction treated by primary angioplasty.
    Catheter Cardiovasc Interv. 2019 Nov 29. doi: 10.1002/ccd.28626.
    PubMed     Abstract available
    
    
    
27. VALLABHAJOSYULA S, El Hajj SC, Bell MR, Prasad A, et al
    Intravascular ultrasound, optical coherence tomography, and fractional flow reserve use in acute myocardial infarction.
    Catheter Cardiovasc Interv. 2019 Nov 14. doi: 10.1002/ccd.28543.
    PubMed     Abstract available
    
    
    
28. ALSANJARI O, Chouari T, Williams T, Myat A, et al
    Angiographically visible coronary artery collateral circulation improves prognosis in patients presenting with acute ST segment-elevation myocardial infarction.
    Catheter Cardiovasc Interv. 2019 Nov 12. doi: 10.1002/ccd.28532.
    PubMed     Abstract available
    
    
    
29. XENOGIANNIS I, Nikolakopoulos I, Vemmou E, Brilakis ES, et al
    Chronic total occlusion recanalization for myocardial infarction.
    Catheter Cardiovasc Interv. 2019 Nov 6. doi: 10.1002/ccd.28590.
    PubMed     Abstract available
    
    
    October 2019
30. BATCHELOR R, Liu DH, Bloom J, Noaman S, et al
    Association of periprocedural intravenous morphine use on clinical outcomes in ST-elevation myocardial infarction (STEMI) treated by primary percutaneous coronary intervention: Systematic review and meta-analysis.
    Catheter Cardiovasc Interv. 2019 Oct 26. doi: 10.1002/ccd.28561.
    PubMed     Abstract available
    
    
    
31. CANTOR WJ, Lavi S, Dzavik V, Cairns J, et al
    Upstream anticoagulation for patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: Insights from the TOTAL trial.
    Catheter Cardiovasc Interv. 2019 Oct 15. doi: 10.1002/ccd.28540.
    PubMed     Abstract available
    
    
    
32. IGLESIAS-GARRIZ I, Delgado I, Prieto-Salvador I, Garrote C, et al
    Previously diagnosed cancer and mortality after ST-segment elevation acute myocardial infarction treated with primary angioplasty.
    Catheter Cardiovasc Interv. 2019 Oct 4. doi: 10.1002/ccd.28506.
    PubMed     Abstract available
    
    
    August 2019
33. MARQUIS-GRAVEL G, Zeitouni M, Kochar A, Jones WS, et al
    Technical consideration in acute myocardial infarction with cardiogenic shock: A review of antithrombotic and PCI therapies.
    Catheter Cardiovasc Interv. 2019 Aug 21. doi: 10.1002/ccd.28455.
    PubMed     Abstract available
    
    
    
34. KIM YH, Her AY, Jeong MH, Kim BK, et al
    Impact of stent generation on 2-year clinical outcomes in ST-segment elevation myocardial infarction patients with multivessel disease who underwent culprit-only or multivessel percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2019 Aug 18. doi: 10.1002/ccd.28440.
    PubMed     Abstract available
    
    
    July 2019
35. CASTRO-MEJIA AF, Ortega-Armas ME, Mejia-Renteria H, Gonzalo N, et al
    Short-term clinical outcomes of percutaneous coronary intervention of unprotected left main coronary disease in cardiogenic shock.
    Catheter Cardiovasc Interv. 2019 Jul 26. doi: 10.1002/ccd.28404.
    PubMed     Abstract available
    
    
    
36. KOLTOWSKI L, Tomaniak M, Ochijewicz D, Maksym J, et al
    Second generation, sirolimus-eluting, bioresorbable Tyrocore scaffold implantation in patients with ST-segment elevation myocardial infarction: Baseline OCT and 30-day clinical outcomes - A FANTOM STEMI pilot study.
    Catheter Cardiovasc Interv. 2019 Jul 25. doi: 10.1002/ccd.28414.
    PubMed     Abstract available
    
    
    
37. POSTMA W, Fabris E, Van der Ent M, Hermanides R, et al
    Resolute zotarolimus-eluting stent in ST-elevation myocardial infarction (resolute-STEMI): A prespecified prospective register from the DAPT-STEMI trial.
    Catheter Cardiovasc Interv. 2019 Jul 3. doi: 10.1002/ccd.28376.
    PubMed     Abstract available
    
    
    June 2019
38. SHAH R, Naz A
    Postprocedure bivalirudin infusion for primary percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2019 Jun 26. doi: 10.1002/ccd.28377.
    PubMed    
    
    
    
39. CHEN W, Lu D, Huang Z, Xiao L, et al
    Is a prolongation of bivalirudin infusion needed in patients with STEMI undergoing percutaneous coronary intervention?
    Catheter Cardiovasc Interv. 2019 Jun 10. doi: 10.1002/ccd.28368.
    PubMed    
    
    
    
40. TRIPATHI B, Yeh RW, Bavishi CP, Sardar P, et al
    Etiologies, trends, and predictors of readmission in ST-elevation myocardial infarction patients undergoing multivessel percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2019 Jun 4. doi: 10.1002/ccd.28344.
    PubMed     Abstract available
    
    
    
41. PRICE DJ, Levy MS
    CYP2C19 pharmacogenetics in patients undergoing coronary stent placement: Is it time to test everyone?
    Catheter Cardiovasc Interv. 2019;93:1253-1254.
    PubMed     Abstract available
    
    
    May 2019
42. INOGUCHI Y, Kaku B, Kitagawa N, Katsuda S, et al
    Novel use of a stent graft for uncontrollable intraprocedural stent thrombosis in a patient with acute myocardial infarction.
    Catheter Cardiovasc Interv. 2019 May 29. doi: 10.1002/ccd.28346.
    PubMed     Abstract available
    
    
    
43. MONTERO CABEZAS JM, Abou R, Goedemans L, Aguero J, et al
    Procedural-related coronary atrial branch occlusion during primary percutaneous coronary intervention for ST-segment elevation myocardial infarction and atrial arrhythmias at follow-up.
    Catheter Cardiovasc Interv. 2019 May 29. doi: 10.1002/ccd.28351.
    PubMed     Abstract available
    
    
    
44. KIM N, Lee JH, Jang SY, Bae MH, et al
    Intravascular modality-guided versus angiography-guided percutaneous coronary intervention in acute myocardial infarction.
    Catheter Cardiovasc Interv. 2019 May 27. doi: 10.1002/ccd.28359.
    PubMed     Abstract available
    
    
    
45. DESCH S, Thiele H
    Letter commenting on: Outcomes of multivessel vs culprit lesion-only percutaneous coronary intervention in patients with acute myocardial infarction complicated by cardiogenic shock: Evidence from an updated meta-analysis (Kundu et al. Catheter Cardio
    Catheter Cardiovasc Interv. 2019 May 15. doi: 10.1002/ccd.28331.
    PubMed    
    
    
    
46. KUNDU A, Sardar P, Kakouros N, Fisher DZ, et al
    Rebuttal: Response to letter by Desch et al. regarding "Outcomes of multivessel vs. culprit lesion-only percutaneous coronary intervention in patients with acute myocardial infarction complicated by cardiogenic shock: Evidence from an updated meta-ana
    Catheter Cardiovasc Interv. 2019 May 15. doi: 10.1002/ccd.28334.
    PubMed    
    
    
    
47. BAUER T, Zeymer U, Diallo A, Vicaut E, et al
    Impact of preprocedural TIMI flow on clinical outcome in low-risk patients with ST-elevation myocardial infarction: Results from the ATLANTIC study.
    Catheter Cardiovasc Interv. 2019 May 8. doi: 10.1002/ccd.28318.
    PubMed     Abstract available
    
    
    
48. KARATASAKIS A, Brilakis ES
    Chronic total occlusion percutaneous coronary intervention failure: Learning from failure.
    Catheter Cardiovasc Interv. 2019;93:1039-1040.
    PubMed     Abstract available
    
    
    
49. KALYANASUNDARAM A, Seth A
    Chronic total occlusion or non-chronic total occlusion percutaneous coronary intervention: Do myocytes really care?
    Catheter Cardiovasc Interv. 2019;93:1067-1068.
    PubMed     Abstract available
    
    
    April 2019
50. MOSCARELLA E, Ielasi A, Beneduce A, Ferrante G, et al
    One-year clinical outcome of biodegradable polymer sirolimus-eluting stent in patients presenting with acute myocardial infarction: Insight from the ULISSE registry.
    Catheter Cardiovasc Interv. 2019 Apr 29. doi: 10.1002/ccd.28305.
    PubMed     Abstract available
    
    
    
51. POZZI M, Flagiello M, Armoiry X, Generali T, et al
    Extracorporeal life support in the multidisciplinary management of cardiogenic shock complicating acute myocardial infarction.
    Catheter Cardiovasc Interv. 2019 Apr 29. doi: 10.1002/ccd.28316.
    PubMed     Abstract available
    
    
    
52. VAN NUNEN LX, van 't Veer M, Zimmermann FM, Wijnbergen I, et al
    Intra-aortic balloon pump counterpulsation in extensive myocardial infarction with persistent ischemia: The SEMPER FI pilot study.
    Catheter Cardiovasc Interv. 2019 Apr 24. doi: 10.1002/ccd.28289.
    PubMed     Abstract available
    
    
    
53. HANNAN EL, Wu Y, Tamis-Holland J, Jacobs AK, et al
    Sex differences in the treatment and outcomes of patients hospitalized with ST-elevation myocardial infarction.
    Catheter Cardiovasc Interv. 2019 Apr 22. doi: 10.1002/ccd.28286.
    PubMed     Abstract available
    
    
    
54. TIJSSEN RYG, van der Schaaf RJ, Kraak RP, Vink MA, et al
    Clinical outcomes at 2 years of the Absorb bioresorbable vascular scaffold versus the Xience drug-eluting metallic stent in patients presenting with acute coronary syndrome versus stable coronary disease-AIDA trial substudy.
    Catheter Cardiovasc Interv. 2019 Apr 9. doi: 10.1002/ccd.28193.
    PubMed     Abstract available
    
    
    
55. KAPUR NK, O'Neill WW
    Left ventricular end-diastolic pressure in acute myocardial infarction: A loaded target in need of unloading.
    Catheter Cardiovasc Interv. 2019;93:910-911.
    PubMed     Abstract available
    
    
    March 2019
56. SEJR-HANSEN M, Westra J, Thim T, Christiansen EH, et al
    Quantitative flow ratio for immediate assessment of nonculprit lesions in patients with ST-segment elevation myocardial infarction-An iSTEMI substudy.
    Catheter Cardiovasc Interv. 2019 Mar 25. doi: 10.1002/ccd.28208.
    PubMed     Abstract available
    
    
    
57. JIMENEZ-QUEVEDO P, Brugaletta S, Cequier A, Iniguez A, et al
    Long-term impact of diabetes in patients with ST-segment elevation myocardial infarction: Insights from the EXAMINATION randomized trial.
    Catheter Cardiovasc Interv. 2019 Mar 20. doi: 10.1002/ccd.28194.
    PubMed     Abstract available
    
    
    
58. CRIMI G, Moramarco L, Mandurino-Mirizzi A, Quaretti P, et al
    The combined use of stent retriever and neuro-aspiration as successful bail-out reperfusion strategy in a patient with embolic myocardial infarction.
    Catheter Cardiovasc Interv. 2019 Mar 9. doi: 10.1002/ccd.28167.
    PubMed     Abstract available
    
    
    
59. DERIMAY F, Rioufol G, Finet G
    Letter by Derimay et al regarding the article: "Coronary bifurcation bench test using multimodality imaging: Impact of stent strut link location on stent deformity and jailed side-branch orifices during reproximal optimizing technique" by Kume et al.
    Catheter Cardiovasc Interv. 2019 Mar 6. doi: 10.1002/ccd.28178.
    PubMed    
    
    
    
60. SETO AH, Kern MJ
    The calculus of preloading antiplatelet agents in ST-elevation myocardial infarction: Does it make a difference?
    Catheter Cardiovasc Interv. 2019;93:602-603.
    PubMed     Abstract available
    
    
    
61. SHATILA W, Krajcer Z
    Does single-valve surgery cause ischemia?
    Catheter Cardiovasc Interv. 2019;93:590-591.
    PubMed     Abstract available
    
    
    
62. PARIKH PB, Reilly JP
    Closing the gender gap (but not the generation gap) in acute coronary syndromes.
    Catheter Cardiovasc Interv. 2019;93:E259-E260.
    PubMed     Abstract available
    
    
    
63. MONTGOMERY JE, Levy MS
    STEMIs and Coumadin: Are they an unsafe combination?
    Catheter Cardiovasc Interv. 2019;93:E257-E258.
    PubMed     Abstract available
    
    
    February 2019
64. ATTI V, Patel NJ, Kumar V, Tripathi B, et al
    Frequency of 30-day readmission and its causes after percutaneous coronary intervention in acute myocardial infarction complicated by cardiogenic shock.
    Catheter Cardiovasc Interv. 2019 Feb 27. doi: 10.1002/ccd.28161.
    PubMed     Abstract available
    
    
    
65. FU Y, Gu XS, Hao GZ, Jiang YF, et al
    Comparison of myocardial microcirculatory perfusion after catheter-administered intracoronary thrombolysis with anisodamine versus standard thrombus aspiration in patients with ST-elevation myocardial infarction.
    Catheter Cardiovasc Interv. 2019 Feb 17. doi: 10.1002/ccd.28112.
    PubMed     Abstract available
    
    
    
66. BUTMAN S
    No Option? Maybe just a matter of time, as in No Option for now?
    Catheter Cardiovasc Interv. 2019;93:E187-E188.
    PubMed     Abstract available
    
    
    
67. PATEL NJ, Heuser RR
    PCI on a tear: Not all perforations need coverage.
    Catheter Cardiovasc Interv. 2019;93:426-427.
    PubMed     Abstract available
    
    
    
68. BUTMAN SM, Paris R
    I do not want to go to the hospital again.
    Catheter Cardiovasc Interv. 2019;93:380-381.
    PubMed     Abstract available
    
    
    
69. LALL SK, Gilchrist IC
    Roadmap for the radial: Should we stop for directions?
    Catheter Cardiovasc Interv. 2019;93:E195-E196.
    PubMed     Abstract available
    
    
    
70. BELARDI JA, Lamelas P
    Impella support for chronic total occlusions angioplasty: A good start.
    Catheter Cardiovasc Interv. 2019;93:E191-E192.
    PubMed     Abstract available
    
    
    
71. DAVIDSON LJ, Davidson CJ
    CAD strategy in the TAVR era.
    Catheter Cardiovasc Interv. 2019;93:553-554.
    PubMed     Abstract available
    
    
    
72. ANOUTI K, Gray W
    The Aortix device: Support in a tube.
    Catheter Cardiovasc Interv. 2019;93:434-435.
    PubMed     Abstract available
    
    
    
73. WANG Y, Zhao HW, Wang CF, Fan CY, et al
    Efficacy and safety of bivalirudin during percutaneous coronary intervention in high-bleeding-risk elderly patients with chronic total occlusion: A prospective randomized controlled trial.
    Catheter Cardiovasc Interv. 2019 Feb 5. doi: 10.1002/ccd.28087.
    PubMed     Abstract available
    
    
    
74. GILCHRIST IC
    Heparin, bivalirudin, or the best of both for STEMI interventions.
    Catheter Cardiovasc Interv. 2019;93:248-249.
    PubMed     Abstract available
    
    
    
75. CLAESSEN BE, Dangas GD
    Leave nothing behind: Promising results for coronary drug-coated balloons in clinical practice.
    Catheter Cardiovasc Interv. 2019;93:189-190.
    PubMed     Abstract available
    
    
    
76. BUTMAN S
    Great report, food for thought, or wait a second?
    Catheter Cardiovasc Interv. 2019;93:264-265.
    PubMed     Abstract available
    
    
    
77. HALL AB, Brilakis ES
    Hybrid 2.0: Subintimal plaque modification for facilitation of future success in chronic total occlusion percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2019;93:199-201.
    PubMed     Abstract available
    
    
    
78. RILEY RF, Walsh SJ, Kirtane AJ, Michael Wyman R, et al
    Algorithmic solutions to common problems encountered during chronic total occlusion angioplasty: The algorithms within the algorithm.
    Catheter Cardiovasc Interv. 2019;93:286-297.
    PubMed     Abstract available
    
    
    
79. GOLESKI PJ, Nakamura K, Liebeskind E, Salisbury AC, et al
    Revascularization of coronary chronic total occlusions with subintimal tracking and reentry followed by deferred stenting: Experience from a high-volume referral center.
    Catheter Cardiovasc Interv. 2019;93:191-198.
    PubMed     Abstract available
    
    
    
80. MONTEFUSCO A, D'Ascenzo F, Gili S, Smolka G, et al
    Self-expandable sirolimus-eluting stents compared to second-generation drug-eluting stents for the treatment of the left main: A propensity score analysis from the SPARTA and the FAILS-2 registries.
    Catheter Cardiovasc Interv. 2019;93:208-215.
    PubMed     Abstract available
    
    
    
81. ROSENBERG M, Waliszewski M, Chin K, Ahmad WAW, et al
    Prospective, large-scale multicenter trial for the use of drug-coated balloons in coronary lesions: The DCB-only All-Comers Registry.
    Catheter Cardiovasc Interv. 2019;93:181-188.
    PubMed     Abstract available
    
    
    
82. AOUN J, Lahsaei S, Zahm C, Bhat T, et al
    Validation and comparison of non-hyperemic pressure reserve to fractional flow reserve for assessment of coronary artery stenosis: A real world study.
    Catheter Cardiovasc Interv. 2019;93:250-255.
    PubMed     Abstract available
    
    
    
83. CLAESSEN BE, Henriques JPS, Vendrik J, Boerlage-van Dijk K, et al
    Paclitaxel-eluting balloon versus everolimus-eluting stent in patients with diabetes mellitus and in-stent restenosis: Insights from the randomized DARE trial.
    Catheter Cardiovasc Interv. 2019;93:216-221.
    PubMed     Abstract available
    
    
    
84. BLACHUTZIK F, Achenbach S, Trobs M, Marwan M, et al
    Effect of non-compliant balloon postdilatation on magnesium-based bioresorbable vascular scaffolds.
    Catheter Cardiovasc Interv. 2019;93:202-207.
    PubMed     Abstract available
    
    
    
85. INGRASSIA J, Youn YJ, Lee J, Azrin M, et al
    Novel approach to coronary artery perforation repair.
    Catheter Cardiovasc Interv. 2019;93:E98-E100.
    PubMed     Abstract available
    
    
    January 2019
86. HUANG X, Redfors B, Chen S, Gersh BJ, et al
    Predictors of mortality in patients with non-anterior ST-segment elevation myocardial infarction: Analysis from the HORIZONS-AMI trial.
    Catheter Cardiovasc Interv. 2019 Jan 28. doi: 10.1002/ccd.28096.
    PubMed     Abstract available
    
    
    
87. WU K, Huang Z, Zhong Z, Liao H, et al
    Predictors, treatment, and long-term outcomes of coronary perforation during retrograde percutaneous coronary intervention via epicardial collaterals for recanalization of chronic coronary total occlusion.
    Catheter Cardiovasc Interv. 2019 Jan 28. doi: 10.1002/ccd.28093.
    PubMed     Abstract available
    
    
    
88. HE Y, Zhang D, Yin D, Zhu C, et al
    Development and validation of a risk scoring system based on baseline angiographic results by visual estimation for risk prEdiction of side-branch OccLusion in coronary bifurcation InterVEntion: The baseline V-RESOLVE score.
    Catheter Cardiovasc Interv. 2019 Jan 28. doi: 10.1002/ccd.28068.
    PubMed     Abstract available
    
    
    
89. NDREPEPA G, Cassese S, Hashorva D, Kufner S, et al
    Relationship of left ventricular end-diastolic pressure with extent of myocardial ischemia, myocardial salvage and long-term outcome in patients with ST-segment elevation myocardial infarction.
    Catheter Cardiovasc Interv. 2019 Jan 25. doi: 10.1002/ccd.28098.
    PubMed     Abstract available
    
    
    
90. JIA S, Zhao Y, Yang J, Zhao X, et al
    Impact of baseline estimated glomerular filtration rate on inhospital outcomes of patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: A China acute myocardial infarction registry study.
    Catheter Cardiovasc Interv. 2019 Jan 13. doi: 10.1002/ccd.28060.
    PubMed     Abstract available
    
    
    
91. WANG H, Ning X, Zhu C, Yin D, et al
    Prognostic significance of prior ischemic stroke in patients with coronary artery disease undergoing percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2019 Jan 7. doi: 10.1002/ccd.28057.
    PubMed     Abstract available
    
    
    December 2018
92. CANNON LA, Kimmelstiel CD, White A, Hill R, et al
    Clinical outcomes following implantation of the ION paclitaxel-eluting platinum chromium coronary stent in routine clinical practice: Results of the ION U.S. post-approval study.
    Catheter Cardiovasc Interv. 2018 Dec 30. doi: 10.1002/ccd.28044.
    PubMed     Abstract available
    
    
    
93. KUNDU A, Sardar P, Kakouros N, Malhotra R, et al
    Outcomes of multivessel vs culprit lesion-only percutaneous coronary intervention in patients with acute myocardial infarction complicated by cardiogenic shock: Evidence from an updated meta-analysis.
    Catheter Cardiovasc Interv. 2018 Dec 28. doi: 10.1002/ccd.28062.
    PubMed     Abstract available
    
    
    
94. LIU S, Song C, Zhao Y, Guan C, et al
    Impact of baseline thrombocytopenia on the long-term outcome of patients undergoing elective percutaneous coronary intervention: An analysis of 9,897 consecutive patients.
    Catheter Cardiovasc Interv. 2018 Dec 26. doi: 10.1002/ccd.28030.
    PubMed     Abstract available
    
    
    
95. FABRIS E, Ottervanger JP, Hermanides RS, Ten Berg JM, et al
    Effect of early tirofiban administration on N-terminal pro-B-type natriuretic peptide level in patients treated with primary percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2018 Dec 26. doi: 10.1002/ccd.28043.
    PubMed     Abstract available
    
    
    
96. GAO G, Zhao Y, Zhang D, He Y, et al
    Is the SYNTAX Score II applicable in all percutaneous coronary intervention patients?
    Catheter Cardiovasc Interv. 2018 Dec 14. doi: 10.1002/ccd.28053.
    PubMed     Abstract available
    
    
    November 2018
97. KIM YH, Her AY, Jeong MH, Kim BK, et al
    Two-year outcomes of statin therapy in patients with acute myocardial infarction with or without dyslipidemia after percutaneous coronary intervention in the era of new-generation drug-eluting stents within Korean population: Data from the Korea Acute
    Catheter Cardiovasc Interv. 2018 Nov 25. doi: 10.1002/ccd.27985.
    PubMed     Abstract available
    
    
    
98. XU JJ, Song Y, Jiang P, Gao Z, et al
    Effect of prior stroke on long-term outcomes of percutaneous coronary interventions in Chinese patients: A large single-center study.
    Catheter Cardiovasc Interv. 2018 Nov 13. doi: 10.1002/ccd.27705.
    PubMed     Abstract available
    
    
    
99. GE J, Li J, Dong B, Ning X, et al
    Determinants of angiographic thrombus burden and impact of thrombus aspiration on outcome in young patients with ST-segment elevation myocardial infarction.
    Catheter Cardiovasc Interv. 2018 Nov 12. doi: 10.1002/ccd.27944.
    PubMed     Abstract available
    
    
    October 2018
100. USKELA S, Karkkainen JM, Eranen J, Siljander A, et al
     Percutaneous coronary intervention with drug-coated balloon-only strategy in stable coronary artery disease and in acute coronary syndromes: An all-comers registry study.
     Catheter Cardiovasc Interv. 2018 Oct 31. doi: 10.1002/ccd.27950.
     PubMed     Abstract available
     
     
     
101. GE Z, Baber U, Claessen BE, Farhan S, et al
     The prevalence, predictors and outcomes of guideline-directed medical therapy in patients with acute myocardial infarction undergoing PCI, an analysis from the PROMETHEUS registry.
     Catheter Cardiovasc Interv. 2018 Oct 23. doi: 10.1002/ccd.27860.
     PubMed     Abstract available
     
     
     
102. FABRIS E, Van't Hof A, Hamm CW, Lapostolle F, et al
     Pre-hospital administration of ticagrelor in diabetic patients with ST-elevation myocardial infarction undergoing primary angioplasty: A sub-analysis of the ATLANTIC trial.
     Catheter Cardiovasc Interv. 2018 Oct 9. doi: 10.1002/ccd.27921.
     PubMed     Abstract available
     
     
     
103. FELDMANN K, Cami E, Safian RD
     Planning percutaneous coronary interventions using computed tomography angiography and fractional flow reserve-derived from computed tomography: A state-of-the-art review.
     Catheter Cardiovasc Interv. 2018 Oct 4. doi: 10.1002/ccd.27817.
     PubMed     Abstract available
     
     
     
104. ZIVELONGHI C, van Andel M, Venturi G, Amoroso G, et al
     Angiographic and clinical outcomes of antegrade versus retrograde techniques for chronic total occlusion revascularizations: Insights from the PRISON IV trial.
     Catheter Cardiovasc Interv. 2018 Oct 2. doi: 10.1002/ccd.27795.
     PubMed     Abstract available
     
     
     September 2018
105. OGUNBAYO GO, Misumida N, Ayoub K, Hailemariam Y, et al
     Temporal trends, characteristics and outcomes of fibrinolytic therapy for ST-elevation myocardial infarction among patients 80 years or older.
     Catheter Cardiovasc Interv. 2018 Sep 30. doi: 10.1002/ccd.27833.
     PubMed     Abstract available
     
     
     
106. PEPE M, Cafaro A, Paradies V, Signore N, et al
     Time-dependent benefits of pre-treatment with new oral P2Y12 -inhibitors in patients addressed to primary PCI for acute ST-elevation myocardial infarction.
     Catheter Cardiovasc Interv. 2018 Sep 30. doi: 10.1002/ccd.27863.
     PubMed     Abstract available
     
     
     
107. WANG YS, Zhang J, Li YF, Chen BR, et al
     A pilot clinical study of adjunctive therapy with selective intracoronary hypothermia in patients with ST-segment elevation myocardial infarction.
     Catheter Cardiovasc Interv. 2018 Sep 28. doi: 10.1002/ccd.27864.
     PubMed     Abstract available
     
     
     
108. DAVID SW, Khan ZA, Patel NC, Metzger DC, et al
     Evaluation of intracoronary hyperoxemic oxygen therapy in acute anterior myocardial infarction: The IC-HOT study.
     Catheter Cardiovasc Interv. 2018 Sep 28. doi: 10.1002/ccd.27905.
     PubMed     Abstract available
     
     
     
109. SHETABI K, Ullah R, Patel R, Wilson T, et al
     Contemporary practice pattern of revascularization in a large tertiary care referral center in non-ST elevation myocardial infarction: A propensity-matched 10-year experience.
     Catheter Cardiovasc Interv. 2018 Sep 28. doi: 10.1002/ccd.27839.
     PubMed     Abstract available
     
     
     
110. FUKUTOMI M, Toriumi S, Ogoyama Y, Oba Y, et al
     Outcome of staged percutaneous coronary intervention within two weeks from admission in patients with ST-segment elevation myocardial infarction with multivessel disease.
     Catheter Cardiovasc Interv. 2018 Sep 23:e27896. doi: 10.1002/ccd.27896.
     PubMed     Abstract available
     
     
     
111. KIMURA T, Nishibori Y, Miki K, Maruyama T, et al
     Open sesame technique in percutaneous coronary intervention for ST-elevation myocardial infarction.
     Catheter Cardiovasc Interv. 2018 Sep 23. doi: 10.1002/ccd.27787.
     PubMed     Abstract available
     
     
     
112. IBRAHIM H, Kaltenbach LA, Hess CN, Recchia T, et al
     Glycoprotein IIb/IIIa inhibitor use in patients with acute myocardial infarction undergoing PCI: Insights from the TRANSLATE ACS study.
     Catheter Cardiovasc Interv. 2018 Sep 23. doi: 10.1002/ccd.27816.
     PubMed     Abstract available
     
     
     
113. SHAUKAT A, Mooney M, Burke MN, Brilakis ES, et al
     Use of chronic total occlusion percutaneous coronary intervention techniques for treating acute vessel closure.
     Catheter Cardiovasc Interv. 2018 Sep 14. doi: 10.1002/ccd.27868.
     PubMed     Abstract available
     
     
     
114. OKUMURA H, Hayashi H, Harada M, Mikuri M, et al
     Retrograde percutaneous coronary intervention for acute myocardial infarction following blunt chest trauma.
     Catheter Cardiovasc Interv. 2018 Sep 12. doi: 10.1002/ccd.27836.
     PubMed     Abstract available
     
     
     
115. BOI A, Sanna F, Rossi A, Loi B, et al
     Acute myocardial infarction secondary to blunt chest trauma in motorcycle accident: A rare combination where percutaneous coronary intervention and intravascular imaging optimization are needed.
     Catheter Cardiovasc Interv. 2018 Sep 12. doi: 10.1002/ccd.27725.
     PubMed     Abstract available
     
     
     
116. BEZERRA CG, Hideo-Kajita A, Bulant CA, Maso-Talou GD, et al
     Coronary fractional flow reserve derived from intravascular ultrasound imaging: Validation of a new computational method of fusion between anatomy and physiology.
     Catheter Cardiovasc Interv. 2018 Sep 12. doi: 10.1002/ccd.27822.
     PubMed     Abstract available
     
     
     
117. BRUGALETTA S, Cequier A, Alfonso F, Iniguez A, et al
     MAGnesium-based bioresorbable scaffold and vasomotor function in patients with acute ST segment elevation myocardial infarction: The MAGSTEMI trial: Rationale and design.
     Catheter Cardiovasc Interv. 2018 Sep 9. doi: 10.1002/ccd.27825.
     PubMed     Abstract available
     
     
     
118. BUSSE T, Reifart J, Reifart N
     Influence of novel X-ray imaging technology on radiation exposure during chronic total occlusion procedures.
     Catheter Cardiovasc Interv. 2018 Sep 9. doi: 10.1002/ccd.27785.
     PubMed     Abstract available
     
     
     
119. KORNOWSKI R, Levi A
     Periprocedural myocardial infarction in chronic total occlusion: The challenge of precise diagnosis and prognostication.
     Catheter Cardiovasc Interv. 2018;92:486-487.
     PubMed     Abstract available
     
     
     
120. CLAESSEN BE, Mehran R
     How to manage chronic total occlusions in the setting of acute myocardial infarction complicated by cardiogenic shock?
     Catheter Cardiovasc Interv. 2018;92:464-465.
     PubMed     Abstract available
     
     
     July 2018
121. NOAMAN S, Goh CY, Vogrin S, Brennan AL, et al
     Comparison of short-term clinical outcomes of proximal versus nonproximal lesion location in patients treated with primary percutaneous coronary intervention for ST-elevation myocardial infarction: The PROXIMITI study.
     Catheter Cardiovasc Interv. 2018 Jul 18. doi: 10.1002/ccd.27665.
     PubMed     Abstract available
     
     
     
122. WUSTROW I, Sarafoff N, Haller B, Rossner L, et al
     Real clinical experiences of dual versus triple antithrombotic therapy after percutaneous coronary intervention.
     Catheter Cardiovasc Interv. 2018 Jul 18. doi: 10.1002/ccd.27678.
     PubMed     Abstract available
     
     
     
123. CHEN GC, Lu XM, Song YM, Gyawail L, et al
     A 3-year experience of a simple, novel technique for accurate ostial/non-ostial coronary stenting: The buddy balloon anchor stent technique.
     Catheter Cardiovasc Interv. 2018 Jul 18. doi: 10.1002/ccd.27667.
     PubMed     Abstract available
     
     
     
124. SMILOWITZ NR, Mohananey D, Razzouk L, Weisz G, et al
     Impact and trends of intravascular imaging in diagnostic coronary angiography and percutaneous coronary intervention in inpatients in the United States.
     Catheter Cardiovasc Interv. 2018 Jul 18. doi: 10.1002/ccd.27673.
     PubMed     Abstract available
     
     
     
125. LOTFI A, Davies JE, Fearon WF, Grines CL, et al
     Focused update of expert consensus statement: Use of invasive assessments of coronary physiology and structure: A position statement of the society of cardiac angiography and interventions.
     Catheter Cardiovasc Interv. 2018 Jul 3. doi: 10.1002/ccd.27672.
     PubMed    
     
     
     June 2018
126. KERN MJ, Seto AH
     Bifurcation lesion assessment with advanced quantitative coronary angiography: A method still wanting.
     Catheter Cardiovasc Interv. 2018;91:1271-1272.
     PubMed     Abstract available
     
     
     May 2018
127. GUL B, Kozuma K, Haimi I, Zhao W, et al
     Sex disparities in acute myocardial infarction care and outcomes.
     Catheter Cardiovasc Interv. 2018 May 10. doi: 10.1002/ccd.27622.
     PubMed     Abstract available
     
     
     
128. VOLZ S, Angeras O, Odenstedt J, Ioanes D, et al
     Sustained risk of stent thrombosis and restenosis in first generation drug-eluting Stents after One Decade of Follow-up: A Report from the Swedish Coronary Angiography and Angioplasty Registry (SCAAR).
     Catheter Cardiovasc Interv. 2018 May 10. doi: 10.1002/ccd.27655.
     PubMed     Abstract available
     
     
     
129. AKODAD M, Huet F, Dupuy AM, Lotierzo M, et al
     Letter to the editor concerning "comparative prognostic value of postprocedural creatine kinase myocardial band and high-sensitivity troponin T in patients with non-ST-segment elevation myocardial infarction undergoing percutaneous coronary interventi
     Catheter Cardiovasc Interv. 2018 May 4. doi: 10.1002/ccd.27618.
     PubMed    
     
     
     
130. TAMEZ H, Genereux P, Yeh RW, Amin AP, et al
     Cost implications of intraprocedural thrombotic events and bleeding in percutaneous coronary intervention: Results from the CHAMPION PHOENIX ECONOMICS Study.
     Catheter Cardiovasc Interv. 2018 May 4. doi: 10.1002/ccd.27638.
     PubMed     Abstract available
     
     
     
131. JACKSON M, Austin D, Kwok CS, Rashid M, et al
     The impact of diabetes on the prognostic value of left ventricular function following percutaneous coronary intervention: Insights from the British Cardiovascular Intervention Society.
     Catheter Cardiovasc Interv. 2018 May 4. doi: 10.1002/ccd.27642.
     PubMed     Abstract available
     
     
     April 2018
132. MCNEICE A, Nadra IJ, Robinson SD, Fretz E, et al
     The prognostic impact of revascularization strategy in acute myocardial infarction and cardiogenic shock: Insights from the British Columbia Cardiac Registry.
     Catheter Cardiovasc Interv. 2018 Apr 26. doi: 10.1002/ccd.27648.
     PubMed     Abstract available
     
     
     
133. SETO AH, Kern MJ
     Early stent thrombosis: Nearly gone, but never forgotten.
     Catheter Cardiovasc Interv. 2018;91:849-850.
     PubMed     Abstract available
     
     
     
134. KHAN AA, Dangas GD
     The quest for a "diabetic" stent.
     Catheter Cardiovasc Interv. 2018;91:892-893.
     PubMed     Abstract available
     
     
     March 2018
135. NDREPEPA G, Kastrati A
     Rebuttal: Comparative prognostic value of postprocedural creatine kinase myocardial band and high-sensitivity troponin T in patients with non-ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention.
     Catheter Cardiovasc Interv. 2018 Mar 30. doi: 10.1002/ccd.27617.
     PubMed    
     
     
     
136. YE J, Lee AJ, Blanke P, Webb J, et al
     The first transapical transcatheter aortic valve-in-valve implantation using the J-valve system into a failed biophysio aortic prosthesis in a patient with high risk of coronary obstruction.
     Catheter Cardiovasc Interv. 2018 Mar 30. doi: 10.1002/ccd.27604.
     PubMed     Abstract available
     
     
     
137. GOINS AE, Rayson R, Caughey MC, Sola M, et al
     Correlation of infarct size with invasive hemodynamics in patients with ST-elevation myocardial infarction.
     Catheter Cardiovasc Interv. 2018 Mar 25. doi: 10.1002/ccd.27625.
     PubMed     Abstract available
     
     
     
138. BARREIRA G, Costa JR Jr, Costa R, Staico R, et al
     Serial intravascular ultrasound evaluation of the DESolve novolimus-eluting bioresorbable coronary scaffold system.
     Catheter Cardiovasc Interv. 2018 Mar 9. doi: 10.1002/ccd.27591.
     PubMed     Abstract available
     
     
     
139. NIIDA T, Murai T, Yonetsu T, Kanaji Y, et al
     Coronary physiological assessment combining fractional flow reserve and index of microcirculatory resistance in patients undergoing elective percutaneous coronary intervention with grey zone fractional flow reserve.
     Catheter Cardiovasc Interv. 2018 Mar 8. doi: 10.1002/ccd.27570.
     PubMed     Abstract available
     
     
     
140. GOLDSWEIG AM, Wang Y, Forrest JK, Cleman MW, et al
     Ventricular septal rupture complicating acute myocardial infarction: Incidence, treatment, and outcomes among medicare beneficiaries 1999-2014.
     Catheter Cardiovasc Interv. 2018 Mar 7. doi: 10.1002/ccd.27576.
     PubMed     Abstract available
     
     
     
141. ANANTHAKRISHNA R, Kristanto W, Liu L, Chan SP, et al
     Incidence and predictors of target lesion failure in a multiethnic Asian population receiving the SYNERGY coronary stent: A prospective all-comers registry.
     Catheter Cardiovasc Interv. 2018 Mar 7. doi: 10.1002/ccd.27577.
     PubMed     Abstract available
     
     
     
142. KHAN AA, Dangas GD
     Coronary chronic total occlusions: How to dilate the tough ones.
     Catheter Cardiovasc Interv. 2018;91:667-668.
     PubMed     Abstract available
     
     
     
143. TAJTI P, Karmpaliotis D, Alaswad K, Toma C, et al
     Prevalence, Presentation and Treatment of 'Balloon Undilatable' Chronic Total Occlusions: Insights from a Multicenter US Registry.
     Catheter Cardiovasc Interv. 2018;91:657-666.
     PubMed     Abstract available
     
     
     
144. WON KB, Yoon HJ, Lee SG, Cho YK, et al
     Comparison of long-term mortality according to obesity in patients with successful percutaneous chronic total occlusion interventions using drug-eluting stents.
     Catheter Cardiovasc Interv. 2018;91:710-716.
     PubMed     Abstract available
     
     
     
145. TAKAGI H, Ando T, Umemoto T
     Drug-eluting stents versus coronary artery bypass grafting for left-main coronary artery disease.
     Catheter Cardiovasc Interv. 2018;91:697-709.
     PubMed     Abstract available
     
     
     
146. GEBHARD C, Gick M, Ferenc M, Stahli BE, et al
     Coronary dominance and prognosis in patients with chronic total occlusion treated with percutaneous coronary intervention.
     Catheter Cardiovasc Interv. 2018;91:669-678.
     PubMed     Abstract available
     
     
     
147. LI C, Xu R, Shen Y, Dai Y, et al
     Bivalirudin in percutaneous coronary intervention for chronic total occlusion: A single-center pilot study.
     Catheter Cardiovasc Interv. 2018;91:679-685.
     PubMed     Abstract available
     
     
     
148. VAN BOVEN N, van Domburg RT, Kardys I, Umans VA, et al
     Development and validation of a risk model for long-term mortality after percutaneous coronary intervention: The IDEA-BIO Study.
     Catheter Cardiovasc Interv. 2018;91:686-695.
     PubMed     Abstract available
     
     
     
149. AZZALINI L, Carlino M, Brilakis ES, Vo M, et al
     Subadventitial techniques for chronic total occlusion percutaneous coronary intervention: The concept of "vessel architecture".
     Catheter Cardiovasc Interv. 2018;91:725-734.
     PubMed     Abstract available
     
     
     February 2018
150. DAUTOV R, Ybarra LF, Nguyen CM, Gibrat C, et al
     Incidence, predictors and longer-term impact of troponin elevation following hybrid chronic total occlusion percutaneous coronary intervention.
     Catheter Cardiovasc Interv. 2018 Feb 26. doi: 10.1002/ccd.27545.
     PubMed     Abstract available
     
     
     
151. AMINIAN A, Saito S, Takahashi A, Bernat I, et al
     Impact of sheath size and hemostasis time on radial artery patency after transradial coronary angiography and intervention in Japanese and non-Japanese patients: A substudy from RAP and BEAT (Radial Artery Patency and Bleeding, Efficacy, Adverse evenT
     Catheter Cardiovasc Interv. 2018 Feb 16. doi: 10.1002/ccd.27526.
     PubMed     Abstract available
     
     
     
152. BRILAKIS ES, Eckman P
     The five key "ingredients" for improving outcomes in cardiogenic shock complicating acute myocardial infarction.
     Catheter Cardiovasc Interv. 2018;91:462-463.
     PubMed     Abstract available
     
     
     
153. BUTMAN S
     KISS for in-stent restenosis.
     Catheter Cardiovasc Interv. 2018;91:434.
     PubMed     Abstract available
     
     
     
154. URETSKY BF
     All stent strut malappositions are not created equal.
     Catheter Cardiovasc Interv. 2018;91:376-377.
     PubMed     Abstract available
     
     
     
155. CAPRANZANO P, Capodanno D, Brugaletta S, Latib A, et al
     Clinical outcomes of patients with diabetes mellitus treated with Absorb bioresorbable vascular scaffolds: a subanalysis of the European Multicentre GHOST-EU Registry.
     Catheter Cardiovasc Interv. 2018;91:444-453.
     PubMed     Abstract available
     
     
     
156. GASPARINI GL, Oreglia JA, Reimers B
     Self-apposing stent-assisted coil embolization for the treatment of coronary artery aneurysm.
     Catheter Cardiovasc Interv. 2018;91:470-474.
     PubMed     Abstract available
     
     
     
157. PURI R, Otaegui I, Sabate M, Serra-Penaranda A, et al
     Three- and 6-month optical coherence tomographic surveillance following percutaneous coronary intervention with the Angiolite(R) drug-eluting stent: The ANCHOR study.
     Catheter Cardiovasc Interv. 2018;91:435-443.
     PubMed     Abstract available
     
     
     
158. WALDO SW, O'Donnell CI, Prouse A, Plomondon ME, et al
     Incidence, procedural management, and clinical outcomes of coronary in-stent restenosis: Insights from the National VA CART Program.
     Catheter Cardiovasc Interv. 2018;91:425-433.
     PubMed     Abstract available
     
     
     
159. SETHI A, Singbal Y, Rastogi U, Prasad VS, et al
     Late Incomplete stent apposition is associated with late/very late stent thrombosis: A meta-analysis.
     Catheter Cardiovasc Interv. 2018;91:365-375.
     PubMed     Abstract available
     
     
     
160. QIAN F, Zhong Y, Hannan EL
     Four-year comparative effectiveness of bare-metal and everolimus-eluting stents in New York.
     Catheter Cardiovasc Interv. 2018;91:417-424.
     PubMed     Abstract available
     
     
     
161. ROZEMEIJER R, Stein M, Frambach P, Voskuil M, et al
     Rationale and design of amphilimus sirolimus-eluting stents versus zotarolimus-eluting stents in all-comers requiring percutaneous coronary intervention (ReCre8): A multicenter randomized clinical trial.
     Catheter Cardiovasc Interv. 2018;91:410-416.
     PubMed     Abstract available
     
     
     
162. VAN BOMMEL RJ, Lemmert ME, van Mieghem NM, van Geuns RJ, et al
     Occurrence and predictors of acute stent recoil-A comparison between the xience prime cobalt chromium stent and the promus premier platinum chromium stent.
     Catheter Cardiovasc Interv. 2018;91:E21-E28.
     PubMed     Abstract available
     
     
     
163. CAMPOS CM, Caixeta A, Franken M, Bartorelli AL, et al
     Risk and timing of clinical events according to diabetic status of patients treated with everolimus-eluting bioresorbable vascular scaffolds versus everolimus-eluting stent: 2-year results from a propensity score matched comparison of ABSORB EXTEND an
     Catheter Cardiovasc Interv. 2018;91:387-395.
     PubMed     Abstract available
     
     
     
164. GAO G, Feng L, Zhang D, Song C, et al
     Proximal left anterior descending coronary artery stenosis should be considered when using the prognostic value of the residual SYNTAX score: Data from 10343 consecutive patients with long-term follow up in the real world.
     Catheter Cardiovasc Interv. 2018;91.
     PubMed     Abstract available
     
     
     
165. AFOLABI A, Mustafina I, Zhao L, Li L, et al
     Does spotty calcification attenuate the response of nonculprit plaque to statin therapy?: A serial optical coherence tomography study.
     Catheter Cardiovasc Interv. 2018;91.
     PubMed     Abstract available
     
     
     
166. ZHAO Z, Zhang D, Xu B, Wang H, et al
     Is side branch lesion length an independent predictor of acute side branch occlusion in provisional strategy? Analysis of 524 consecutive bifurcation lesions.
     Catheter Cardiovasc Interv. 2018;91.
     PubMed     Abstract available
     
     
     
167. HE Y, Zhang D, Yin D, Zhu C, et al
     Validation of the V-RESOLVE (Visual Estimation for Risk prEdiction of Side Branch OccLusion in Coronary Bifurcation interVEntion) score system.
     Catheter Cardiovasc Interv. 2018;91.
     PubMed     Abstract available
     
     
     
168. XU JJ, Gao Z, Zhang Y, Gao LJ, et al
     Dual antiplatelet therapy after coronary drug-eluting stent implantation in China: A large single center study.
     Catheter Cardiovasc Interv. 2018;91.
     PubMed     Abstract available
     
     
     
169. SONG L, Li J, Guan C, Jing Q, et al
     Randomized comparison of novel biodegradable polymer and durable polymer-coated cobalt-chromium sirolimus-eluting stents: Three-Year Outcomes of the I-LOVE-IT 2 Trial.
     Catheter Cardiovasc Interv. 2018;91.
     PubMed     Abstract available
     
     
     
170. SONG L, Guan C, Yan H, Qiao S, et al
     Validation of contemporary risk scores in predicting coronary thrombotic events and major bleeding in patients with acute coronary syndrome after drug-eluting stent implantations.
     Catheter Cardiovasc Interv. 2018;91.
     PubMed     Abstract available
     
     
     
171. MURAI T, Yonetsu T, Kanaji Y, Usui E, et al
     Prognostic value of the index of microcirculatory resistance after percutaneous coronary intervention in patients with non-ST-segment elevation acute coronary syndrome.
     Catheter Cardiovasc Interv. 2018 Feb 15. doi: 10.1002/ccd.27529.
     PubMed     Abstract available
     
     
     
172. ZIVELONGHI C, van Kuijk JP, Nijenhuis V, Poletti E, et al
     First report of the use of long-tapered sirolimus-eluting coronary stent for the treatment of chronic total occlusions with the hybrid algorithm.
     Catheter Cardiovasc Interv. 2018 Feb 7. doi: 10.1002/ccd.27539.
     PubMed     Abstract available
     
     
     
173. SAWANT AC, Bhardwaj A, Banerjee K, Jobanputra Y, et al
     Fractional flow reserve guided percutaneous coronary intervention results in reduced ischemic myocardium and improved outcomes.
     Catheter Cardiovasc Interv. 2018 Feb 6. doi: 10.1002/ccd.27525.
     PubMed     Abstract available
     
     
     
174. ZHANG BC, Tu SX, Karanasos A, van Geuns RJ, et al
     Association of stent-induced changes in coronary geometry with late stent failure: Insights from three-dimensional quantitative coronary angiographic analysis.
     Catheter Cardiovasc Interv. 2018 Feb 5. doi: 10.1002/ccd.27520.
     PubMed     Abstract available
     
     
     
175. WANG XZ, Zhang YJ, Fu GS, Jing QM, et al
     One-year clinical outcomes and multislice computed tomography angiographic results following implantation of the NeoVas bioresorbable sirolimus-eluting scaffold in patients with single de novo coronary artery lesions.
     Catheter Cardiovasc Interv. 2018 Feb 2. doi: 10.1002/ccd.27491.
     PubMed     Abstract available
     
     
     
176. CHATTERJEE A, Hillegass WB
     The promise of effective P2Y12 platelet receptor pretreatment: Not crushed yet.
     Catheter Cardiovasc Interv. 2018;91:251-252.
     PubMed     Abstract available
     
     
     
177. BRILAKIS ES, Krestyaninov O
     Wanted: Expert operators for coronary chronic total occlusion interventions.
     Catheter Cardiovasc Interv. 2018;91:180-181.
     PubMed     Abstract available
     
     
     
178. PLITT A, Dangas G
     Cardiac enzyme elevation after coronary revascularization.
     Catheter Cardiovasc Interv. 2018;91:224-225.
     PubMed     Abstract available
     
     
     
179. BUTMAN SM
     If not now, why are you waiting?
     Catheter Cardiovasc Interv. 2018;91:265-266.
     PubMed     Abstract available
     
     
     
180. MISUMIDA N, Moliterno DJ
     Hybrid coronary revascularization: Time for a new comparator?
     Catheter Cardiovasc Interv. 2018;91:213-214.
     PubMed     Abstract available
     
     
     
181. MAHMOUD AN, Saad M, Elgendy AY, Mentias A, et al
     Deferred or immediate stent implantation for primary percutaneous coronary intervention: A meta-analysis of randomized trials.
     Catheter Cardiovasc Interv. 2018;91:260-264.
     PubMed     Abstract available
     
     
     
182. MCGARVEY M, Ali O, Iqbal MB, Ilsley C, et al
     A feasibility and safety study of intracoronary hemodilution during primary coronary angioplasty in order to reduce reperfusion injury in myocardial infarction.
     Catheter Cardiovasc Interv. 2018;91:234-241.
     PubMed     Abstract available
     
     
     
183. YOON MH, Tahk SJ, Lim HS, Yang HM, et al
     Myocardial Mass Contributes to the Discrepancy Between Anatomic Stenosis Severity Assessed by Intravascular Ultrasound and Fractional Flow Reserve in Intermediate Lesions of the Coronary Artery.
     Catheter Cardiovasc Interv. 2018;91:182-191.
     PubMed     Abstract available
     
     
     
184. NDREPEPA G, Colleran R, Braun S, Xhepa E, et al
     Comparative prognostic value of postprocedural creatine kinase myocardial band and high-sensitivity troponin T in patients with non-ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention.
     Catheter Cardiovasc Interv. 2018;91:215-223.
     PubMed     Abstract available
     
     
     
185. ARORA S, Matsushita K, Qamar A, Stacey RB, et al
     Early versus late percutaneous revascularization in patients hospitalized with non ST-segment elevation myocardial infarction: The atherosclerosis risk in communities surveillance study.
     Catheter Cardiovasc Interv. 2018;91:253-259.
     PubMed     Abstract available
     
     
     
186. SARDAR P, Kundu A, Bischoff M, Chatterjee S, et al
     Hybrid coronary revascularization versus coronary artery bypass grafting in patients with multivessel coronary artery disease: A meta-analysis.
     Catheter Cardiovasc Interv. 2018;91:203-212.
     PubMed     Abstract available
     
     
     
187. MAEREMANS J, Spratt JC, Knaapen P, Walsh S, et al
     Towards a contemporary, comprehensive scoring system for determining technical outcomes of hybrid percutaneous chronic total occlusion treatment: The RECHARGE score.
     Catheter Cardiovasc Interv. 2018;91:192-202.
     PubMed     Abstract available
     
     
     January 2018
188. LIU S, Song C, Zhao Y, Zhu C, et al
     The impact of acquired thrombocytopenia on long-term outcomes of patients undergoing elective percutaneous coronary intervention: An analysis of 8,271 consecutive patients.
     Catheter Cardiovasc Interv. 2018 Jan 25. doi: 10.1002/ccd.27498.
     PubMed     Abstract available
     
     
     
189. DONG H, Che W, Jiang X, Peng M, et al
     Carotid artery stenting followed by open heart surgery in 323 patients: One-year results and influencing factors.
     Catheter Cardiovasc Interv. 2018 Jan 22. doi: 10.1002/ccd.27486.
     PubMed     Abstract available
     
     
     
190. XU N, Tang XF, Yao Y, Zhao X, et al
     Predictive value of neutrophil to lymphocyte ratio in long-term outcomes of left main and/or three-vessel disease in patients with acute myocardial infarction.
     Catheter Cardiovasc Interv. 2018 Jan 13. doi: 10.1002/ccd.27495.
     PubMed     Abstract available
     
     
     
191. VO MN, Brilakis ES, Grantham JA
     Novel use of cutting balloon to treat subintimal hematomas during chronic total occlusion interventions.
     Catheter Cardiovasc Interv. 2018;91:53-56.
     PubMed     Abstract available
     
     
     
192. GASPARINI GL, Oreglia JA, Garbo R
     The trap and occlude technique for retrograde wire externalization during chronic total occlusion revascularization.
     Catheter Cardiovasc Interv. 2018;91:57-63.
     PubMed     Abstract available
     
     
     
193. BRUGALETTA S, Gomez-Lara J, Caballero J, Ortega-Paz L, et al
     TIcaGrEloR and Absorb bioresorbable vascular scaffold implantation for recovery of vascular function after successful chronic total occlusion recanalization (TIGER-BVS trial): Rationale and study design.
     Catheter Cardiovasc Interv. 2018;91:1-6.
     PubMed     Abstract available
     
     
     
194. TARANTINI G, Mojoli M, Masiero G, Cortese B, et al
     Clinical outcomes of overlapping versus non-overlapping everolimus-eluting absorb bioresorbable vascular scaffolds: An analysis from the multicentre prospective RAI registry (ClinicalTrials.gov identifier: NCT02298413).
     Catheter Cardiovasc Interv. 2018;91:E1-E16.
     PubMed     Abstract available
     
     
     
195. CORTESE B, Rigattieri S, Aranzulla TC, Russo F, et al
     Transradial versus transfemoral ancillary approach in complex structural, coronary, and peripheral interventions. Results from the multicenter ancillary registry: A study of the Italian Radial Club.
     Catheter Cardiovasc Interv. 2018;91:97-102.
     PubMed     Abstract available
     
     
     December 2017
196. KIM JH, Kim BK, Kim S, Ahn CM, et al
     Incidence, predicting factors, and clinical outcomes of periprocedural myocardial infarction after percutaneous coronary intervention for chronic total occlusion in the era of new-generation drug-eluting stents.
     Catheter Cardiovasc Interv. 2017 Dec 20. doi: 10.1002/ccd.27420.
     PubMed     Abstract available
     
     
     
197. BASIR MB, Schreiber T, Dixon S, Alaswad K, et al
     Feasibility of early mechanical circulatory support in acute myocardial infarction complicated by cardiogenic shock: The Detroit cardiogenic shock initiative.
     Catheter Cardiovasc Interv. 2017 Dec 20. doi: 10.1002/ccd.27427.
     PubMed     Abstract available
     
     
     
198. MILLAN-ITURBE O, Sawaya FJ, Lonborg J, Chow DHF, et al
     Coronary artery disease, revascularization, and clinical outcomes in transcatheter aortic valve replacement: Real-world results from the East Denmark Heart Registry.
     Catheter Cardiovasc Interv. 2017 Dec 7. doi: 10.1002/ccd.27440.
     PubMed     Abstract available
     
     
     
199. GIUSTINO G, Dangas GD
     Ischemia-reperfusion injury and ischemic post-conditioning in acute myocardial infarction: Lost in translation.
     Catheter Cardiovasc Interv. 2017;90:1068-1069.
     PubMed     Abstract available
     
     
     November 2017
200. DANIELS DV, Banerjee S, Alaswad K, Doing AH, et al
     Safety and efficacy of the hybrid approach in coronary chronic total occlusion percutaneous coronary intervention: The Hybrid Video Registry.
     Catheter Cardiovasc Interv. 2017 Nov 29. doi: 10.1002/ccd.26501.
     PubMed     Abstract available
     
     
     
201. GOLDSTEIN JA
     Peri-procedural myocardial infarction: Plaques and patients "at-risk".
     Catheter Cardiovasc Interv. 2017;90:915-916.
     PubMed     Abstract available
     
     
     
202. MURATA N, Takayama T, Hiro T, Hirayama A, et al
     Balloon pin-hole rupture during percutaneous coronary intervention for recurrent, calcified in-stent restenosis: A case report.
     Catheter Cardiovasc Interv. 2017 Nov 13. doi: 10.1002/ccd.27405.
     PubMed     Abstract available
     
     
     
203. STAHLI BE, Gebhard C, Gick M, Ferenc M, et al
     Impact of anemia on long-term outcomes after percutaneous coronary intervention for chronic total occlusion.
     Catheter Cardiovasc Interv. 2017 Nov 11. doi: 10.1002/ccd.27412.
     PubMed     Abstract available
     
     
     
204. D'ASCENZO F, Iannaccone M, Pavani M, Kawamoto H, et al
     Planned angiographic control versus clinical follow-up for patients with unprotected left main stem stenosis treated with second generation drug-eluting stents: A propensity score with matching analysis from the FAILS (failure in left main with second
     Catheter Cardiovasc Interv. 2017 Nov 11. doi: 10.1002/ccd.27408.
     PubMed     Abstract available
     
     
     October 2017
205. GOYAL A, Tabak SW, Henry TD, Kobashigawa JA, et al
     Omission of heart transplant recipients from the 2017 Appropriate Use Criteria for Coronary Revascularization in patients with stable ischemic heart disease.
     Catheter Cardiovasc Interv. 2017 Oct 31. doi: 10.1002/ccd.27369.
     PubMed    
     
     
     
206. BARAN DA, Visveswaran GK, Seliem A, DiVita M, et al
     Differential responses to larger volume intra-aortic balloon counterpulsation: Hemodynamic and clinical outcomes.
     Catheter Cardiovasc Interv. 2017 Oct 31. doi: 10.1002/ccd.27387.
     PubMed     Abstract available
     
     
     
207. ARORA S, Vaidya SR, Strassle PD, Misenheimer JA, et al
     Meta-analysis of transfemoral TAVR versus surgical aortic valve replacement.
     Catheter Cardiovasc Interv. 2017 Oct 25. doi: 10.1002/ccd.27357.
     PubMed     Abstract available
     
     
     
208. LIANG M, Yang S, Fu N, Lu C, et al
     Efficacy of alprostadil in preventing contrast-induced nephropathy in patients undergoing percutaneous coronary intervention: A multicenter prospective randomized controlled trial.
     Catheter Cardiovasc Interv. 2017 Oct 10. doi: 10.1002/ccd.27353.
     PubMed     Abstract available
     
     
     
209. EFFRON MB, Wang TY, Fonarow GC, Henry TD, et al
     The safety and effectiveness of adenosine diphosphate receptor inhibitor pretreatment among acute myocardial infarction patients treated with percutaneous coronary intervention in community practice: Insights from the TRANSLATE-ACS study.
     Catheter Cardiovasc Interv. 2017 Oct 8. doi: 10.1002/ccd.27145.
     PubMed     Abstract available
     
     
     September 2017
210. YUDI MB, Farouque O, Andrianopoulos N, Ajani AE, et al
     Pretreatment with dual antiplatelet therapy in patients with ST-elevation myocardial infarction.
     Catheter Cardiovasc Interv. 2017 Sep 30. doi: 10.1002/ccd.27325.
     PubMed     Abstract available
     
     
     
211. WATANABE H, Morimoto T, Shiomi H, Kawaji T, et al
     Chronic total occlusion in non-infarct-related artery is associated with increased short-and long-term mortality in patients with ST-segment elevation acute myocardial infarction complicated by cardiogenic shock (from the CREDO-Kyoto AMI registry).
     Catheter Cardiovasc Interv. 2017 Sep 30. doi: 10.1002/ccd.27330.
     PubMed     Abstract available
     
     
     
212. AZZALINI L, Candilio L, Carlino M, Colombo A, et al
     Intracoronary snaring of the retrograde guidewire: How to overcome extreme takeoff angles in chronic total occlusion percutaneous coronary intervention.
     Catheter Cardiovasc Interv. 2017 Sep 25. doi: 10.1002/ccd.27324.
     PubMed     Abstract available
     
     
     
213. GIUSTINO G, Dangas GD
     Integrating invasive hemodynamic parameters into risk stratification of acute myocardial infarction and cardiogenic shock.
     Catheter Cardiovasc Interv. 2017;90:396-397.
     PubMed     Abstract available
     
     
     August 2017
214. HUCZEK Z, Zbronski K, Grodecki K, Scislo P, et al
     Concomitant coronary artery disease and its management in patients referred to transcatheter aortic valve implantation: Insights from the POL-TAVI Registry.
     Catheter Cardiovasc Interv. 2017 Aug 26. doi: 10.1002/ccd.27251.
     PubMed     Abstract available
     
     
     
215. BHARADWAJ AS, Bhatheja S, Sharma SK, Kini AS, et al
     Utility of the guideliner catheter for percutaneous coronary interventions in patients with prior transcatheter aortic valve replacement.
     Catheter Cardiovasc Interv. 2017 Aug 10. doi: 10.1002/ccd.27211.
     PubMed     Abstract available
     
     
     
216. AGRAWAL M, Hakeem A, Ahmed Z, Uretsky BF, et al
     Classification of mechanisms of strut malapposition after angiographically optimized stent implantation: An optical coherence tomography study.
     Catheter Cardiovasc Interv. 2017;90:225-232.
     PubMed     Abstract available
     
     
     July 2017
217. MANGELS DR, Giri J, Hirshfeld J, Wilensky RL, et al
     Robotic-assisted percutaneous coronary intervention.
     Catheter Cardiovasc Interv. 2017 Jul 19. doi: 10.1002/ccd.27205.
     PubMed     Abstract available
     
     
     
218. CLAESSEN BE, van den Boogert TPW, Piek JJ
     Recurrent myocardial infarction in a 47-year-old woman with a mechanical mitral valve prosthesis: Atherosclerosis, embolism, or spasm?
     Catheter Cardiovasc Interv. 2017 Jul 12. doi: 10.1002/ccd.27186.
     PubMed     Abstract available
     
     
     
219. MIGLIORINI A, Valenti R, Vergara R, Grazia De Gregorio M, et al
     Angiographic and clinical outcome after crush of everolimus-eluting stent for distal unprotected left main disease.
     Catheter Cardiovasc Interv. 2017;90:72-77.
     PubMed     Abstract available
     
     
     June 2017
220. LUONG C, Starovoytov A, Heydari M, Sedlak T, et al
     Clinical presentation of patients with spontaneous coronary artery dissection.
     Catheter Cardiovasc Interv. 2017;89:1149-1154.
     PubMed     Abstract available
     
     
     
221. LUNI FK, Riaz H, Khan AR, Riaz T, et al
     Clinical outcomes associated with per-operative discontinuation of aspirin in patients with coronary artery disease: A systematic review and meta-analysis.
     Catheter Cardiovasc Interv. 2017;89:1168-1175.
     PubMed     Abstract available
     
     
     May 2017
222. BRENER MI, Bush A, Miller JM, Hasan RK, et al
     Influence of radial versus femoral access site on coronary angiography and intervention outcomes: A systematic review and meta-analysis.
     Catheter Cardiovasc Interv. 2017 May 25. doi: 10.1002/ccd.27043.
     PubMed     Abstract available
     
     
     
223. SARNO G, Lagerqvist B, Olivecrona G, Varenhorst C, et al
     Real-life clinical outcomes with everolimus eluting platinum chromium stent with an abluminal biodegradable polymer in patients from the Swedish Coronary Angiography and Angioplasty Registry (SCAAR).
     Catheter Cardiovasc Interv. 2017 May 22. doi: 10.1002/ccd.27030.
     PubMed     Abstract available
     
     
     
224. VERDOIA M, Barbieri L, Parodi G, Bellandi B, et al
     Impact of anticoagulation strategy with bivalirudin or heparin on nonaccess site bleeding in percutaneous coronary interventions: A meta-analysis of randomized trials.
     Catheter Cardiovasc Interv. 2017 May 4. doi: 10.1002/ccd.26967.
     PubMed     Abstract available
     
     
     
225. SETO AH, Dehghani P, Shah B, Anwaruddin S, et al
     Late breaking trials of 2016 in coronary artery disease: Commentary covering SCAI, ACC, TCT, EuroPCR, ESC, and AHA.
     Catheter Cardiovasc Interv. 2017;89:1028-1034.
     PubMed     Abstract available
     
     
     
226. MORIYAMA N, Tanaka Y, Saito S
     Bailout polytetrafluoroethylene-covered stent implantation for left main bifurcation perforation using the kissing stent technique.
     Catheter Cardiovasc Interv. 2017;89:1022-1027.
     PubMed     Abstract available
     
     
     
227. WERNER GS, Glaser P, Coenen A, Moehlis H, et al
     Reduction of radiation exposure during complex interventions for chronic total coronary occlusions: Implementing low dose radiation protocols without affecting procedural success rates.
     Catheter Cardiovasc Interv. 2017;89:1005-1012.
     PubMed     Abstract available
     
     
     
228. BOURAS G, Jhamnani S, Ng VG, Haimi I, et al
     Clinical outcomes after PCI treatment of very long lesions with the XIENCE V everolimus eluting stent; Pooled analysis from the SPIRIT and XIENCE V USA prospective multicenter trials.
     Catheter Cardiovasc Interv. 2017;89:984-991.
     PubMed     Abstract available
     
     
     
229. ANDRADE PB, Mattos LA, Rinaldi FS, Bienert IC, et al
     Comparison of a vascular closure device versus the radial approach to reduce access site complications in non-ST-segment elevation acute coronary syndrome patients: The angio-seal versus the radial approach in acute coronary syndrome trial.
     Catheter Cardiovasc Interv. 2017;89:976-982.
     PubMed     Abstract available
     
     
     April 2017
230. SCHREIBER T, Wah Htun W, Blank N, Telila T, et al
     Real-world supported unprotected left main percutaneous coronary intervention with impella device; data from the USpella registry.
     Catheter Cardiovasc Interv. 2017 Apr 18. doi: 10.1002/ccd.26979.
     PubMed     Abstract available
     
     
     
231. MALLIDI JR, Robinson P, Visintainer PF, Lotfi AS, et al
     Comparison of antithrombotic agents during urgent percutaneous coronary intervention following thrombolytic therapy: A retrospective cohort study.
     Catheter Cardiovasc Interv. 2017 Apr 18. doi: 10.1002/ccd.27042.
     PubMed     Abstract available
     
     
     March 2017
232. MINA GS, Firouzbakht T, Modi K, Dominic P, et al
     Gender-based outcomes of bivalirudin versus heparin in patients undergoing percutaneous coronary interventions: Meta-analysis of randomized controlled trials.
     Catheter Cardiovasc Interv. 2017 Mar 24. doi: 10.1002/ccd.26985.
     PubMed     Abstract available
     
     
     
233. VISHNEVSKY A, Julien HM, Fischman DL, Walinsky P, et al
     Unrecognized coronary vasospasm in patients referred for percutaneous coronary intervention: Intracoronary nitroglycerin, the forgotten stepchild of cardiovascular guidelines.
     Catheter Cardiovasc Interv. 2017 Mar 20. doi: 10.1002/ccd.27034.
     PubMed     Abstract available
     
     
     
234. KARIMI GALOUGAHI K, Mintz GS, Karmpaliotis D, Ali ZA, et al
     Zero-contrast percutaneous coronary intervention on calcified lesions facilitated by rotational atherectomy.
     Catheter Cardiovasc Interv. 2017 Mar 17. doi: 10.1002/ccd.26999.
     PubMed     Abstract available
     
     
     
235. SUKUL D, Seth M, Schreiber T, Khandelwal A, et al
     The comparative safety and effectiveness of bivalirudin versus heparin monotherapy in patients on dialysis undergoing percutaneous coronary intervention: Insights from the Blue Cross Blue Shield of Michigan cardiovascular consortium.
     Catheter Cardiovasc Interv. 2017 Mar 17. doi: 10.1002/ccd.27001.
     PubMed     Abstract available
     
     
     
236. MAHMOUD AN, Elgendy IY, Mentias A, Saad M, et al
     Percutaneous coronary intervention or coronary artery bypass grafting for unprotected left main coronary artery disease.
     Catheter Cardiovasc Interv. 2017 Mar 15. doi: 10.1002/ccd.26970.
     PubMed     Abstract available
     
     
     
237. ROMAGNOLI E, Gatto L, La Manna A, Burzotta F, et al
     Role of residual acute stent malapposition in percutaneous coronary interventions.
     Catheter Cardiovasc Interv. 2017 Mar 15. doi: 10.1002/ccd.26974.
     PubMed     Abstract available
     
     
     
238. WILSON WM, Walsh SJ, Bagnall A, Yan AT, et al
     One-year outcomes after successful chronic total occlusion percutaneous coronary intervention.
     Catheter Cardiovasc Interv. 2017 Mar 15. doi: 10.1002/ccd.26980.
     PubMed     Abstract available
     
     
     
239. MENTIAS A, Mahmoud AN, Elgendy IY, Elgendy AY, et al
     Ischemic postconditioning during primary percutaneous coronary intervention.
     Catheter Cardiovasc Interv. 2017 Mar 15. doi: 10.1002/ccd.26965.
     PubMed     Abstract available
     
     
     
240. ARAI T, Lefevre T, Hovasse T, Garot P, et al
     Incidence and predictors of coronary obstruction following transcatheter aortic valve implantation in the real world.
     Catheter Cardiovasc Interv. 2017 Mar 15. doi: 10.1002/ccd.26982.
     PubMed     Abstract available
     
     
     
241. SHARMA D, Kotowycz MA, Sharma V, Choudhury A, et al
     Characteristics and outcomes of patients undergoing percutaneous coronary intervention within 1 year of coronary artery bypass graft surgery.
     Catheter Cardiovasc Interv. 2017 Mar 7. doi: 10.1002/ccd.26853.
     PubMed     Abstract available
     
     
     February 2017
242. CZARNY MJ, Hwang CW, Naiman DQ, Lemmon CC, et al
     Heparin versus bivalirudin for non-primary percutaneous coronary intervention: A post-Hoc analysis of the CPORT-E trial.
     Catheter Cardiovasc Interv. 2017 Feb 4. doi: 10.1002/ccd.26953.
     PubMed     Abstract available
     
     
     
243. VISVESWARAN GK, Cohen M, Seliem A, DiVita M, et al
     A single center tertiary care experience utilizing the large volume mega 50cc intra-aortic balloon counterpulsation in contemporary clinical practice.
     Catheter Cardiovasc Interv. 2017 Feb 1. doi: 10.1002/ccd.26908.
     PubMed     Abstract available
     
     
     December 2016
244. NOMAN A, Balasubramaniam K, Alhous MH, Lee K, et al
     Mortality after percutaneous coronary revascularization: Prior cardiovascular risk factor control and improved outcomes in patients with diabetes mellitus.
     Catheter Cardiovasc Interv. 2016 Dec 28. doi: 10.1002/ccd.26882.
     PubMed     Abstract available
     
     
     November 2016
245. WIMMER NJ, Dufour AB, Cho K, Gagnon DR, et al
     Long-term outcomes in patients with acute coronary syndromes related to prolonging dual antiplatelet therapy more than 12 months after coronary stenting.
     Catheter Cardiovasc Interv. 2016 Nov 10. doi: 10.1002/ccd.26831.
     PubMed     Abstract available
     
     
     
246. CHENG R, Vanichsarn C, Patel JK, Currier J, et al
     Long-term clinical and angiographic outcomes of percutanenous coronary intervention with everolimus-eluting stents for the treatment of cardiac allograft vasculopathy.
     Catheter Cardiovasc Interv. 2016 Nov 10. doi: 10.1002/ccd.26830.
     PubMed     Abstract available
     
     
     
247. SHAH R, Matin K, Rogers KC, Rao SV, et al
     Effect of post-primary percutaneous coronary intervention bivalirudin infusion on net adverse clinical events and mortality: A comprehensive pairwise and network meta-analysis of randomized controlled trials.
     Catheter Cardiovasc Interv. 2016 Nov 10. doi: 10.1002/ccd.26859.
     PubMed     Abstract available
     
     
     September 2016
248. CHANDRASEKHAR J, Bansilal S, Baber U, Sartori S, et al
     Impact of proton pump inhibitors and dual antiplatelet therapy cessation on outcomes following percutaneous coronary intervention: Results From the PARIS Registry.
     Catheter Cardiovasc Interv. 2016 Sep 21. doi: 10.1002/ccd.26716.
     PubMed     Abstract available
     
     
     
249. SUKUL D, Seth M, Dixon SR, Zainea M, et al
     Clinical outcomes of percutaneous coronary intervention in patients turned down for surgical revascularization.
     Catheter Cardiovasc Interv. 2016 Sep 21. doi: 10.1002/ccd.26781.
     PubMed     Abstract available
     
     
     August 2016
250. KANG SJ, Yang DH, Koo HJ, Yun SC, et al
     Intravascular ultrasound-derived morphological predictors of myocardial ischemia assessed by stress myocardial perfusion computed tomography.
     Catheter Cardiovasc Interv. 2016 Aug 27. doi: 10.1002/ccd.26710.
     PubMed     Abstract available
     
     
     
251. PYXARAS SA, Toth GG, Di Gioia G, Ughi GJ, et al
     Anatomical and functional assessment of Tryton bifurcation stent before and after final kissing balloon dilatation: Evaluations by three-dimensional coronary angiography, optical coherence tomography imaging and fractional flow reserve.
     Catheter Cardiovasc Interv. 2016 Aug 27. doi: 10.1002/ccd.26777.
     PubMed     Abstract available
     
     
     
252. ROGGEN M, Dubois C, Gewillig M
     Coronary artery stenting in a patient with progeria.
     Catheter Cardiovasc Interv. 2016 Aug 27. doi: 10.1002/ccd.26730.
     PubMed     Abstract available
     
     
     
253. DANEK BA, Karatasakis A, Alame AJ, Nguyen-Trong PJ, et al
     Saphenous vein graft near-infrared spectroscopy imaging insights from the lipid core plaque association with clinical events near-infrared spectroscopy (ORACLE-NIRS) registry.
     Catheter Cardiovasc Interv. 2016 Aug 18. doi: 10.1002/ccd.26696.
     PubMed     Abstract available
     
     
     
254. FERKO N, Ferrante G, Hasegawa JT, Schikorr T, et al
     Cost-effectiveness of percutaneous coronary intervention with cobalt-chromium everolimus eluting stents versus bare metal stents: Results from a patient level meta-analysis of randomized trials.
     Catheter Cardiovasc Interv. 2016 Aug 16. doi: 10.1002/ccd.26700.
     PubMed     Abstract available
     
     
     
255. RHEUDE TA, Xhepa E, Byrne RA
     Markedly different tissue types on optical coherence tomography imaging in a patient with multiple lesion drug-eluting stent in-stent restenosis.
     Catheter Cardiovasc Interv. 2016 Aug 16. doi: 10.1002/ccd.26694.
     PubMed     Abstract available
     
     
     July 2016
256. MANOLY I, Hasan R, Brazier A, Farooq V, et al
     Feasibility of hybrid off pump artery bypass grafting and transaortic transcatheter aortic valve implantation: A case series.
     Catheter Cardiovasc Interv. 2016 Jul 12. doi: 10.1002/ccd.26610.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Ischemic Heart Disease is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: